Lv6
2400 积分 2024-07-25 加入
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
16天前
已完结
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome
17天前
已完结
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
17天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
18天前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
18天前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
18天前
已完结
Resetting autoimmune disease with CAR cell therapies
20天前
已完结
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
20天前
已完结
The Evolving Landscape of CAR T-Cell Therapy in Autoimmune Diseases: A State-of-the-Art Review (2025)
21天前
已完结
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrom
21天前
已关闭
皖公网安备34019202002308
